Firm Update: Highlighting Portfolio Progress

Firm Update: Highlighting Portfolio Progress

‍
Nine years ago, we filed the paperwork to form Questa Capital. Our vision then was to fund positive change in healthcare by backing a select number of bold companies bringing elegant solutions to market and scaled use. That vision remains the core of our strategy, but now it is a story that we think can be told best through our portfolio. Here is a brief update.

The Questa portfolio today stands at 22 companies, which are driving innovation across the medical device, healthcare services and healthcare technology sectors by prioritizing the patient and the medical professionals who serve them. Several are now emerging as potential market leaders and category defining companies. Among them, Calyxo is poised to revolutionize kidney stone treatment, and we have strong conviction that its 2^nd gen product will become the new standard of care for stone removal. DispatchHealth recently announced the signing of a transformative merger to create the country’s most comprehensive provider of advanced medical care at home; Questa acted as lead investor throughout the transaction, and we are excited about the immense future opportunity to deliver hospital care at home, where patients are most comfortable. Free Market Health’s specialty pharmacy marketplace is scaling rapidly and driving greater transparency and value across the ecosystem, which now makes up more than 50% of Rx spend. Medrio is on a mission to assist in the moonshot goal of curing cancer by serving the most innovative life science companies globally with cutting edge applied AI to optimize clinical research. Our newest investment, Ossio, is leveraging advanced material science to improve outcomes in orthopedic procedures with its proprietary bio-absorbable implants.

By our math, companies in the Questa portfolio have interacted with more than 4.5 million patients receiving medical care from licensed providers, shipped more than 750,000 medical devices which then have been used to care for patients several hundreds of millions of times, powered approximately 8,500 clinical trials with over 1.6 million participants, supported over 100 life science therapies on their journey through trials, FDA approval and/or market ramp, and empowered nearly 47,000 healthcare professionals across the healthcare landscape. We are extremely energized to watch and help each company in the portfolio meet the moment and pursue the opportunities in front of them by focusing on elevating patient experiences, reducing cost, and improving patient health.

To better highlight our incredible portfolio companies and reflect our growth as a firm, we unveiled a redesigned website today. Our goal for the redesign is to put the companies and their teams front and center by sharing more about their stories and our partnership with them. We welcome you to check it out: www.questacapital.com.

Ryan, Brad and Shawn